- Investing Ideas
- /
- Hong Kong Healthcare Undervalued Stocks Based On Cash Flows
Hong Kong Healthcare Undervalued Stocks Based On Cash Flows
Results
9
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
9 companies
Jiangxi Rimag Group
Market Cap: HK$7.0b
Invests and operates medical imaging centers in China.
2522
HK$17.61
7D
-3.3%
1Y
-13.3%
Peijia Medical
Market Cap: HK$4.9b
Engages in the research, development, manufacturing, and sales of transcatheter valve therapeutic and neurointerventional procedural medical devices in the People’s Republic of China.
9996
HK$7.30
7D
-4.3%
1Y
170.4%
Shanghai Conant Optical
Market Cap: HK$20.7b
Manufactures and sells resin spectacle lenses in Mainland China, the Americas, Asia, Europe, Oceania, and Africa.
2276
HK$43.22
7D
-6.2%
1Y
202.7%
YSB
Market Cap: HK$6.4b
Develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China.
9885
HK$9.42
7D
-3.7%
1Y
38.9%
Yonghe Medical Group
Market Cap: HK$1.3b
Provides hair-related healthcare services in China.
2279
HK$2.58
7D
-10.4%
1Y
290.9%
MicroPort CardioFlow Medtech
Market Cap: HK$3.5b
A medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People’s Republic of China and internationally.
2160
HK$1.45
7D
-1.4%
1Y
113.2%
Beijing Chunlizhengda Medical Instruments
Market Cap: HK$9.0b
Beijing Chunlizhengda Medical Instruments Co., Ltd.
1858
HK$15.70
7D
-9.8%
1Y
134.3%
MicroPort NeuroScientific
Market Cap: HK$7.7b
Provides neuro-interventional medical devices.
2172
HK$13.38
7D
-1.8%
1Y
73.1%
Zylox-Tonbridge Medical Technology
Market Cap: HK$8.1b
A medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People’s Republic of China and internationally.
2190
HK$25.42
7D
0.08%
1Y
115.4%